- Report
- February 2024
- 250 Pages
Global
From €4804EUR$5,000USD£4,107GBP
- Report
- February 2024
- 175 Pages
Global
From €4804EUR$5,000USD£4,107GBP
- Report
- February 2021
- 360 Pages
United States
From €2306EUR$2,400USD£1,972GBP
- Report
- February 2023
- 250 Pages
Global
From €4804EUR$5,000USD£4,107GBP
- Report
- April 2020
- 67 Pages
Global
From €4756EUR$4,950USD£4,066GBP
- Report
- January 2022
- 110 Pages
Global
From €4564EUR$4,750USD£3,902GBP
- Report
- October 2023
- 88 Pages
India
From €3363EUR$3,500USD£2,875GBP
- Report
- December 2021
- 82 Pages
Asia Pacific
From €4228EUR$4,400USD£3,614GBP
- Report
- May 2024
- 50 Pages
Global
From €2546EUR$2,650USD£2,177GBP
Lopinavir is an antiviral drug used to treat immune disorders, such as HIV and AIDS. It is a protease inhibitor, meaning it works by blocking the action of protease enzymes, which are essential for the replication of the virus. Lopinavir is usually used in combination with other drugs, such as ritonavir, to increase its effectiveness. It is available in both oral and intravenous forms.
Lopinavir is used to treat HIV and AIDS, as well as other immune disorders, such as hepatitis C. It is also used to prevent mother-to-child transmission of HIV. In addition, it is used to treat certain types of influenza, such as avian flu.
The market for lopinavir is highly competitive, with many companies offering the drug. Some of the major players in the market include AbbVie, Bristol-Myers Squibb, Gilead Sciences, Merck, and Pfizer. Other companies include Cipla, Mylan, and Teva Pharmaceuticals. Show Less Read more
